A biomedical stock with momentum
Whole Foods is sagging, so I'm replacing it in my Wall Street Survivor portfolio with biotech company Techne.
Last week I detected some weakness in Whole Foods Market (WFMI) and needed to replace it with a stock that has positive momentum. The chart below should make it obvious why WFMI needed to be cut.
Most of my picks follow what some people call momentum investing. I do not look for patterns, but I do use Barchart to find stocks that deserve to be recognized for their increases in sales and earnings.
Techne (TECH) is just such a stock, so I added it to my Wall Street Survivor portfolio.
Techne is a holding company with two operating units concentrating on hematology controls, which are used in laboratories to check the accuracy of blood analysis instruments, and biotechnology products such as purified proteins and antibodies.
Technical factors to consider:
- 100% Barchart technical buy signal
- Trend Spotter buy signal
- 10 new highs and up 7.89% in the past month
- Relative Strength Index 78.77 and rising
- Trades around 78.37 with a 50 day moving average of 72.82
- Wall Street brokerage analysts have issued five recommendations on this stock.
- There are two strong buy, one buy, two hold and no negative recommendations released.
- Sales are expected to increase by 4.4% this year and 7% next year.
- Earning are projected to increase by 5.7% this year, 8.4% next year and 10.33% annually for the next five years.
- As measured on Motley Fool, there is very positive investor sentiment for this stock to beat the market.
- CAPS members vote 272 to 8 for that to happen.
- The more experienced All Stars vote 104 to 1 for the same result.
| Tags: | investing strategy |
MORE ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
STOCK SCOUTER
StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.
126 | 257 | 459 | 599 | 671 | 682 | 603 | 455 | 269 | 113 |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
LATEST POSTS
Try as the bears might, they couldn't break U.S. stocks. But investors still face frothy prices and considerable headwinds.
FIDELITY VIEWPOINTS
- How to sell covered calls - Fidelity Investments
- Savvy year-end tax moves to consider now - Fidelity Investments
- Seven ways to prepare for tax changes
- Five reasons an annual review is crucial - Fidelity Investments
- Take a look at mid caps now - Fidelity Investments
- State of the sector: Health care - Fidelity Investments
VIDEO ON MSN MONEY
ABOUT
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.